Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies. J of Skin 2020, 4 (6), s95. https://doi.org/10.25251/skin.4.supp.95.